Equine IFN-γ antibody and antigen (recombinant protein)
Diagnostic anti-Equine IFN-γ antibodies pairs and antigen for animal health (animal Equine/Horse tuberculosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-IFN-y-Ag01 | Equine IFN-γ | $3090.00 |
GMP-EQU-IFN-y-Ab01 | Anti-Equine IFN-γ mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-IFN-y-Ab02 | Anti-Equine IFN-γ mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-IFN-y-Ab03 | Anti-Equine IFN-γ human monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-IFN-y-Ab04 | Anti-Equine IFN-γ human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-EQU-IFN-y-Ag01 |
Product Name | Equine IFN-γ |
Target/Biomarker | Equine IFN-γ |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine IFN-γ antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IFN-γ level test of animal Equine/Horse with tuberculosis. |
Tag | His | Reconized/Reactive Specics | Equine IFN-γ |
Product description | Recombinant Equine IFN-γ protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-IFN-y-Ab01,GMP-EQU-IFN-y-Ab02 |
Target/Biomarker | Equine IFN-γ |
Product Name | Anti-Equine IFN-γ mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine IFN-γ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine IFN-γ antibodies in Equine IFN-γ level test of animal Equine/Horse with tuberculosis. |
Product description | Anti-Equine IFN-γ mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine IFN-γ antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-IFN-y-Ab03,GMP-EQU-IFN-y-Ab04 |
Target/Biomarker | Equine IFN-γ |
Product Name | Anti-Equine IFN-γ human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine IFN-γ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine IFN-γ antibodies in Equine IFN-γ level test of animal Equine/Horse with tuberculosis. |
Product description | Anti-Equine IFN-γ mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
IFNγ, or Interferon-gamma, is a versatile and indispensable biomarker within the context of horses (equines). This cytokine plays a central role in the equine immune system's response to inflammatory challenges, particularly those posed by viral infections and intracellular pathogens. Produced by immune cells such as T cells, natural killer cells, and antigen-presenting cells, IFNγ serves as a linchpin in the immune defense of horses.
Structurally, IFNγ is a small protein that exerts its effects by binding to specific cell surface receptors. Upon binding, it initiates a complex signaling cascade that culminates in the activation of various immune effector functions. In the equine immune system, IFNγ's primary function is to activate macrophages, enhancing their ability to recognize, engulf, and eliminate infected cells. This immune cascade is a critical component of the host's defense against viral infections and other intracellular pathogens.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.